| I-17 Leticia Arrington An R package for Automated Generation of Item Response Theory Model NONMEM Control File Wednesday 09:50-11:15 |
| I-20 Magnus Åstrand nonmem2R: An R-package for Visual Predictive Checks and Goodness-of-fit Plots Wednesday 09:50-11:15 |
| I-26 Junjie Ding Pharmacometric drug adherence approach and its application in a clinical setting Wednesday 09:50-11:15 |
| I-41 Julie Bertrand Model-based approach for group sequential and adaptive designs in parallel and cross-over bioequivalence studies Wednesday 09:50-11:15 |
| I-42 Robert Bies On the Multilemma of reproducibility: Stochastic or Deterministic or Stochastic and Deterministic Wednesday 09:50-11:15 |
| I-46 Guillaume Bonnefois A new computational approach to match control subjects to renal impaired patients in pharmacokinetic studies Wednesday 09:50-11:15 |
| I-54 Vincent Buchheit Data scientists for improving efficiency and quality of quantitative clinical pharmacology analyses Wednesday 09:50-11:15 |
| II-02 Markus Krauß Mice with human livers improve First-in-Human prediction of pharmacokinetics Wednesday 15:10-16:40 |
| II-03 Rukmini Kumar Quantitative Systems Pharmacology (QSP) tools to aid in model development and communication: Vantage QSP Modeling Tools (VQM-Tools) Wednesday 15:10-16:40 |
| II-14 So Jin Lee The new era of pharmacokinetic/pharmacodynamic modeling and simulation in drug development in Korea Wednesday 15:10-16:40 |
| II-18 Yisheng Li A semi-mechanistic dose-finding design in oncology using pharmacokinetic/pharmacodynamic modeling Wednesday 15:10-16:40 |
| II-29 Nicolas Luyckx Improving the performances of clinical trial simulations in Simulo using compiled code Wednesday 15:10-16:40 |
| II-30 Yassine Kamal Lyauk Dose Finding in Clinical Development of 60 FDA-Approved Drugs Compared to the Learning versus Confirming Paradigm Wednesday 15:10-16:40 |
| II-72 Nathalie Perdaems Translational PK-RO modelling for a mAb to predict the outcome of the first in human study Wednesday 15:10-16:40 |
| III-22 Jaydeep Sinha Extension of the Janmahasatian fat-free mass model to account for ethnicity-related bias Thursday 09:55-11:20 |
| III-24 Eunjung Song Selection of optimal study design based on the bioequivalence simulation study in highly variable drugs Thursday 09:55-11:20 |
| III-44 Pauline Traynard New library of double absorptions PK models for the MonolixSuite, application to veralipride pharmacokinetics Thursday 09:55-11:20 |
| III-74 Sebastian Wicha TDMxR: an open-source package for model-based therapeutic drug monitoring in R Thursday 09:55-11:20 |
| III-79 Dan Wright Kinetic-pharmacodynamic models in the setting of non-linear drug elimination Thursday 09:55-11:20 |
| III-87 Yang Zhang Ways to improve the efficiency of pharmacometric model implemented in R using deSovle – an example with a PK model for ADC Thursday 09:55-11:20 |
| IV-06 Dimitra Eleftheriadou Aluminium biokinetics: Elucidating the speciation kinetics of the aluminium-citrate system in vitro. Thursday 15:25-16:50 |
| IV-16 Valentina Fermanelli Correlation structure of Apolipoprotein A4, C3, E kinetics parameters Thursday 15:25-16:50 |
| IV-33 Mario Gonzalez Sales Assembling pharmacometric datasets in R: the puzzle package Thursday 15:25-16:50 |
| IV-47 Charlotte Kloft Review of NMLE articles published in clinical journals with a higher impact factor Thursday 15:25-16:50 |
| IV-69 Fabian Jung Simulation of the environmental exposure to fenofibrate nanomaterials based on in vitro- and in silico methods Thursday 15:25-16:50 |
| IV-71 Evangelos Karakitsios A methodology to estimate population pharmacokinetic parameters from aggregate concentration-time data and its application to gevokizumab. Thursday 15:25-16:50 |
| IV-73 Eleni Karatza Investigation of the impact of population parameters describing gastric emptying on bioequivalence metrics Thursday 15:25-16:50 |
